Compass Wealth Management LLC Trims Position in HCA Healthcare, Inc. (NYSE:HCA)

Compass Wealth Management LLC lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 15,621 shares of the company’s stock after selling 671 shares during the quarter. HCA Healthcare accounts for 1.5% of Compass Wealth Management LLC’s portfolio, making the stock its 14th biggest holding. Compass Wealth Management LLC’s holdings in HCA Healthcare were worth $6,349,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of HCA. Global Retirement Partners LLC increased its position in HCA Healthcare by 4.0% in the third quarter. Global Retirement Partners LLC now owns 12,010 shares of the company’s stock worth $4,881,000 after buying an additional 460 shares in the last quarter. Good Life Advisors LLC purchased a new stake in HCA Healthcare in the third quarter worth about $298,000. nVerses Capital LLC increased its position in HCA Healthcare by 38.9% in the third quarter. nVerses Capital LLC now owns 2,500 shares of the company’s stock worth $1,016,000 after buying an additional 700 shares in the last quarter. Rheos Capital Works Inc. purchased a new stake in HCA Healthcare in the third quarter worth about $6,096,000. Finally, Curran Financial Partners LLC purchased a new stake in shares of HCA Healthcare during the third quarter worth about $202,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.7 %

Shares of HCA stock traded down $2.94 on Thursday, reaching $406.29. 274,423 shares of the company’s stock were exchanged, compared to its average volume of 1,136,068. The company’s fifty day simple moving average is $390.17 and its 200 day simple moving average is $349.03. The stock has a market capitalization of $106.41 billion, a PE ratio of 20.40, a P/E/G ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $416.72. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period last year, the business posted $4.29 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were given a $0.66 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. HCA Healthcare’s payout ratio is 13.16%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research analyst reports. KeyCorp initiated coverage on HCA Healthcare in a research report on Friday, October 11th. They set an “overweight” rating and a $475.00 target price for the company. Morgan Stanley began coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price for the company. Oppenheimer increased their price target on HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. UBS Group increased their price target on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Finally, Barclays increased their price target on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research note on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $365.65.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock valued at $6,407,273 in the last quarter. 1.60% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.